St Jude's vascular closure device gets FDA approval:
This article was originally published in Clinica
St Jude Medical has received US FDA approval to market its 6F Angio-Seal vascular closure device, used to seal arterial punctures created during interventional cardiology procedures. The device includes new enhancement techniques that further simplify deployment, eliminating the need to dilate the arterial puncture site. Angio-Seal devices have successfully penetrated the European market and are expected to have a strong impact in the US, said the St Paul, Minneapolis-based company.